The former reported an increase in serum CCL13 in SSc patients when compared to healthy controls, but no correlation was found with clinical signs of vasculopathy such as pitting scars, telangiectasias, or DUs [171]. This evidence concerns the gene CCL13 and systemic sclerosis.